PATENT CLAIM ANALYSIS

Application Number: 15753523
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "274000"]

Abstract:
Present invention relates to a stable pharmaceutical composition comprising intimate mixture of alogliptin and metformin, and suitable pharmaceutically acceptable excipient/s; wherein metformin is present in about 3.3 parts or more parts by weight relative to 100 parts by weight of the total weight of part comprising alogliptin. Invention also encompasses various processes of preparing said pharmaceutical composition and its use in improving glycemic control in adults with type 2 diabetes mellitus.

Claim (Index 14):
The stable pharmaceutical composition according to  claim 2 , additionally comprising one or more antidiabetic agent.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12560292', '15736592', '10023533', '11668536', '13643386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163579275436954
- 35 USC 102 Novelty (BERT): 0.5146427123374034
- Combined Prediction Score: 0.6961864060230663
- Mean Citation Score: 219.546444
- Max Citation Score: 235.07092000000003
- Similarity Product: 143.43284653799773

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test